Abstract

Sepsis is a clinical syndrome with high mortality and morbidity rates. In sepsis, the abrupt release of cytokines by the innate immune system may cause multiorgan failure, leading to septic shock and associated complications. In the presence of a number of systemic disorders, such as sepsis, infections, diabetes, and systemic lupus erythematosus (SLE), cardiorenal syndrome (CRS) type 5 is defined by concomitant cardiac and renal dysfunctions Thus, our study suggests that certain mRNAs and unexplored pathways may pave a way to unravel critical therapeutic targets in three debilitating and interrelated illnesses, namely, sepsis, SLE, and CRS. Sepsis, SLE, and CRS are closely interrelated complex diseases likely sharing an overlapping pathogenesis caused by erroneous gene network activities. We sought to identify the shared gene networks and the key genes for sepsis, SLE, and CRS by completing an integrative analysis. Initially, 868 DEGs were identified in 16 GSE datasets. Based on degree centrality, 27 hub genes were revealed. The gProfiler webtool was used to perform functional annotations and enriched molecular pathway analyses. Finally, core hub genes (EGR1, MMP9, and CD44) were validated using RT-PCR analysis. Our comprehensive multiplex network approach to hub gene discovery is effective, as evidenced by the findings. This work provides a novel research path for a new research direction in multi-omics biological data analysis.

Highlights

  • cardiorenal syndrome (CRS) is an important example of organ cross-talk, whereby interdependency exists between the function of the kidney and heart and vice versa [9,15,16] Mostly, CRS is associated with cardiovascular disease (CVD) and chronic kidney disease (CKD), both of which are intimately linked

  • If our data reveal down expression for any genes that are described as upregulated in the GSE series linked study, this indicates that we chose the wrong samples

  • An association between CRS type 5, sepsis, and systemic lupus erythematosus (SLE) has been discovered in a number of studies

Read more

Summary

Introduction

More reliable biomarkers for early detection and appropriate therapeutic targets are needed to decrease risk assessment. Elevated inflammatory cytokines, such as TNF-α, IL-1β, and IL-6, during sepsis do not provide specific information regarding the development and severity of the disease, and considering them as specific disease clinical markers is not suitable [13]. It has been reported that patients with sepsis and SLE can develop type 5 CRS, where all of these disorders can lead to disease in the heart and kidneys [14]. In sepsis-induced acute CRS-5, there is a fulminant disease process that has a dramatic impact on both the kidneys and heart [19]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call